Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Congenital dyserythropoietic anemia type I: Updated report from the congenital dyserythropoietic anemia registry of North America

Blood (2025) 146 (Supplement 1): 4685.

https://doi.org/10.1182/blood-2025-4685

Published: 2025

Journal Articles

Innate immune lectins shape anti-blood group antibody development and transfusion outcomes

Shang-Chuen Wu, Connie Arthur, Hau-Ming Jan, Ryan Jajosky, Victoria Ortiz, Margaret Granger, Hirotomo Nakahara, Samata Varadkar, Carter Stowell, Raisa Ahmed, Matthew Rathgeber, William Lane, Melissa Yeung, Marie Hollenhorst, Patricia Zerra, Satheesh Chonat, Seth Rakoff-Nahoum, Richard Cummings, Sean Stowell

Blood (2025) 146 (Supplement 1): 544.

https://doi.org/10.1182/blood-2025-544

Published: 2025

Journal Articles

Complement inhibition in pediatrics: Comprehensive infection analysis from a large pediatric single center

Sara Graciaa, Ronak Dave, Logan Pickett, Marianne Yee, Ross Fasano, Gabrielle Dean, Sumit Verma, Roshan George, Stephanie Jernigan, Larry Greenbaum, Michael Briones, Michelle Schoettler, Satheesh Chonat

Blood (2025) 146 (Supplement 1): 1330.

https://doi.org/10.1182/blood-2025-1330

Published: 2025

Journal Articles

Efficacy and safety of mitapivat in pediatric patients with pyruvate kinase deficiency who are not regularly transfused: Results from the Phase 3, global, randomized, double-blind, placebo-controlled ACTIVATE-Kids trial

Blood (2025) 146 (Supplement 1): 4654.

https://doi.org/10.1182/blood-2025-4654

Published: 2025

Journal Articles

Deep neutrophil phenotyping uncovers complement-mediated neutrophil dysregulation in sickle cell disease

William Briones, Seema Patel, Maya Maarouf, Jayre Jones, Michelle Schoettler, David Archer, Sean Stowell, Rabin Tirouvanziam, Satheesh Chonat

Blood (2025) 146 (Supplement 1): 12.

https://doi.org/10.1182/blood-2025-12

Published: 2025

Journal Articles

Complement dysregulation during vaso-occlusive episodes can predict development of acute chest syndrome in pediatric patients with sickle cell disease

Akshaya Arjunan, Maya Maarouf, Adrianna Westbrook, Justin Yoo, Jayre Jones, William Briones, Nwanna Ifendu, Michael Briones, Seema Patel, Clinton Joiner, Sara Graciaa, Sean Stowell, Michelle Schoettler, Satheesh Chonat

Blood (2025) 146 (Supplement 1): 1167.

https://doi.org/10.1182/blood-2025-1167

Published: 2025

Journal Articles

Challenges in PNH and CAD Management Revealed through Educational Interventions over Three Years

Sumera Ackbarali, Tariqa Ackbarali, Katie Kowalski, Shirley D'Sa, Carlos M de Castro, Satheesh Chonat, Catherine M. Broome

Blood (2024) 144 (Supplement 1): 5087.

https://doi.org/10.1182/blood-2024-211593

Published: 2024

Journal Articles

Terminal Complement Activation in Children with Sinusoidal Obstructive Syndrome after Hematopoietic Cell Transplantation

Michelle L Schoettler, Jayre Jones, William Briones, Elyse Bryson, Muna Qayed, Seema R Patel, Katherine Silvis, Adrianna Westbrook, Kirsten M. Williams, Satheesh Chonat

Blood (2024) 144 (Supplement 1): 3509.

https://doi.org/10.1182/blood-2024-205482

Published: 2024

Journal Articles

Placental Abnormalities in the Humanized Mouse Model of Sickle Cell Disease

Christopher Chambliss, Elizabeth Manci, Elizabeth Eldeiry, Earl Fields, Jr., Jesse Bueno, Satheesh Chonat, David R Archer

Blood (2024) 144 (Supplement 1): 2487.

https://doi.org/10.1182/blood-2024-208162

Published: 2024

Journal Articles

COping with acute sickle cell hemolysis

Satheesh Chonat, Sean R. Stowell

Blood (2024) 143 (24): 2452–2453.

https://doi.org/10.1182/blood.2024024710

Published: 2024

Journal Articles

Patients with Sickle Cell Disease Can Demonstrate a Constellation of Symptoms Associated with Hyper-Hemolysis without Recent Transfusion

Erin R. Garrett, Satheesh Chonat, Michael Briones, Margo R. Rollins

Blood (2023) 142 (Supplement 1): 5293.

https://doi.org/10.1182/blood-2023-187100

Published: 2023

Journal Articles

Age, Gvhd Prophylaxis, and Timing Matter in Thrombotic Microangiopathy after Hematopoietic Cell Therapy- a Secondary CIBMTR Analysis

Michelle L Schoettler, Benjamin Watkins, Muna Qayed, Satheesh Chonat, Adrianna Westbrook, Kirsten M Williams

Blood (2023) 142 (Supplement 1): 2153.

https://doi.org/10.1182/blood-2023-174752

Published: 2023

Journal Articles

Acute Chest Syndrome at the Emory University Georgia Comprehensive Sickle Cell Center at Grady Health System

Danielle Cicka, Michelle L Schoettler, Morgan L. McLemore, Fuad El Rassi, Satheesh Chonat

Blood (2023) 142 (Supplement 1): 3886.

https://doi.org/10.1182/blood-2023-191018

Published: 2023

Journal Articles

Characterizing Pregnancy Outcomes in a Humanized Mouse Model of Sickle Cell Disease

Christopher Chambliss, Elizabeth Manci, Earl Fields, Jesse Bueno, Adeola Michael, Satheesh Chonat, David R Archer

Blood (2023) 142 (Supplement 1): 563.

https://doi.org/10.1182/blood-2023-185898

Published: 2023

Journal Articles

Efficacy of Parallel and Crossover Analysis As Well As Pharmacokinetic Similarity Were Confirmed between ABP 959 and Eculizumab Reference Product in Patients with PNH

Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia MC Langemeijer, Satheesh Chonat, Jia Cao, Vincent Chow, Haby Henary

Blood (2023) 142 (Supplement 1): 4092.

https://doi.org/10.1182/blood-2023-186362

Published: 2023

Journal Articles

Preliminary Pharmacodynamic Results from a Multicenter Phase 2/3 Study of Next-Generation HbS Polymerization Inhibitor GBT021601 for the Treatment of Patients with Sickle Cell Disease

Mira Patel Pochron, Adeseye Michael Akinsete, Shehu Umar Abdullahi, Foluke A Fasola, Modupe Idowu, Sharon Pennington, William B Ershler, Marshall Patrick Stagg, Earl Fields, Morgan Sterling, Satheesh Chonat, Yuvika Paliwal, Karena Kong, David R Archer, Adeyemi Adenola, Eleanor A Lisbon

Blood (2023) 142 (Supplement 1): 1155.

https://doi.org/10.1182/blood-2023-188929

Published: 2023

Journal Articles

Erythrocyte Disorders Mimicking Congenital Dyserythropoietic Anemia Based on Bone Marrow Pathology Exposed By Genetic Evaluation

Jacopo Ceolan, Katie Seu, Athina Ntoumaziou, Yasmin Elgammal, Sana Emberesh, Lisa Bilston, Donald Richards, Kathryn E. Dickerson, Satheesh Chonat, Natalia Rydz, Carolyn Lutzko, Ammar Husami, Wenying Zhang, Theodosia A. Kalfa

Blood (2023) 142 (Supplement 1): 2459.

https://doi.org/10.1182/blood-2023-189140

Published: 2023

Journal Articles

Trials in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase 1b CROSSWALK-a and Phase 2a CROSSWALK-c Trials - Crovalimab for the Treatment and Prevention of Vaso-Occlusive Episodes in Sickle Cell Disease

Marco Aurelio Salvino, Bulent Antmen, Frederick Chite Asirwa, Satheesh Chonat, Lucia De Franceschi, Perla Eleftheriou, Adlette Inati, Johnny Mahlangu, Erfan Nur, Salvador Payán-Pernía, Asad Charania, Diana Gradinaru, Allison Hsia, Yves Luder, Thomas Perretti, Sasha Srekovic, Pablo Bartolucci

Blood (2023) 142 (Supplement 1): 1158.

https://doi.org/10.1182/blood-2023-179858

Published: 2023

Journal Articles

Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression

Blood (2023) 142 (12): 1082–1098.

https://doi.org/10.1182/blood.2022018591

Published: 2023

Includes: Supplemental data

Journal Articles

Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria

Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia M.C. Langemeijer, Satheesh Chonat, Vincent Chow, Jean Pan, Yaneth Saportas, Vladimir Hanes, Haby Henary

Blood (2022) 140 (Supplement 1): 8660–8662.

https://doi.org/10.1182/blood-2022-166722

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Congenital dyserythropoietic anemia type I: Updated report from the congenital dyserythropoietic anemia registry of North America

Innate immune lectins shape anti-blood group antibody development and transfusion outcomes

Complement inhibition in pediatrics: Comprehensive infection analysis from a large pediatric single center

Efficacy and safety of mitapivat in pediatric patients with pyruvate kinase deficiency who are not regularly transfused: Results from the Phase 3, global, randomized, double-blind, placebo-controlled ACTIVATE-Kids trial

Deep neutrophil phenotyping uncovers complement-mediated neutrophil dysregulation in sickle cell disease

Complement dysregulation during vaso-occlusive episodes can predict development of acute chest syndrome in pediatric patients with sickle cell disease

Challenges in PNH and CAD Management Revealed through Educational Interventions over Three Years

Terminal Complement Activation in Children with Sinusoidal Obstructive Syndrome after Hematopoietic Cell Transplantation

Placental Abnormalities in the Humanized Mouse Model of Sickle Cell Disease

COping with acute sickle cell hemolysis

Patients with Sickle Cell Disease Can Demonstrate a Constellation of Symptoms Associated with Hyper-Hemolysis without Recent Transfusion

Age, Gvhd Prophylaxis, and Timing Matter in Thrombotic Microangiopathy after Hematopoietic Cell Therapy- a Secondary CIBMTR Analysis

Acute Chest Syndrome at the Emory University Georgia Comprehensive Sickle Cell Center at Grady Health System

Characterizing Pregnancy Outcomes in a Humanized Mouse Model of Sickle Cell Disease

Efficacy of Parallel and Crossover Analysis As Well As Pharmacokinetic Similarity Were Confirmed between ABP 959 and Eculizumab Reference Product in Patients with PNH

Preliminary Pharmacodynamic Results from a Multicenter Phase 2/3 Study of Next-Generation HbS Polymerization Inhibitor GBT021601 for the Treatment of Patients with Sickle Cell Disease

Erythrocyte Disorders Mimicking Congenital Dyserythropoietic Anemia Based on Bone Marrow Pathology Exposed By Genetic Evaluation

Trials in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase 1b CROSSWALK-a and Phase 2a CROSSWALK-c Trials - Crovalimab for the Treatment and Prevention of Vaso-Occlusive Episodes in Sickle Cell Disease

Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression

Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only